BRD5648

CAS No. 2056261-42-6

BRD5648( (R)-BRD0705 )

Catalog No. M26074 CAS No. 2056261-42-6

BRD5648 is an inactive (R)-enantiomer of BRD0705.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 87 In Stock
5MG 83 In Stock
10MG 122 In Stock
25MG 204 In Stock
50MG 277 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRD5648
  • Note
    Research use only, not for human use.
  • Brief Description
    BRD5648 is an inactive (R)-enantiomer of BRD0705.
  • Description
    BRD5648 is an inactive (R)-enantiomer of BRD0705. BRD0705 is a GSK3α inhibitor (IC50: 66 nM; Kd: 4.8 μM) and can be used in acute myeloid leukemia (AML) studies.(In Vitro):BRD5648 does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
  • In Vitro
    BRD5648, the inactive enantiomer of BRD0705, does not induce changes in enzyme phosphorylation or total β-catenin protein stabilization.
  • In Vivo
    ——
  • Synonyms
    (R)-BRD0705
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2056261-42-6
  • Formula Weight
    321.424
  • Molecular Formula
    C20H23N3O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 300 mg/mL (933.36 mM)
  • SMILES
    CC[C@]1(C2=CNNC2=NC2=C1C(=O)CC(C)(C)C2)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GSK-3 Inhibitor XIII

    GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.

  • CP21R7

    A high-affinity, selective GSK3β inhibitor that activates canonical Wnt signaling.

  • RHPS4

    RHPS4 is a potent inhibitor of Telomerase at submicromolar.